BIOTYPE presented a major upgrade to its benchtop diagnostic platform for the fully integrated analysis of molecular biomarker signatures.

With MODAPLEX professional laboratories in clinical and research settings can now perform highly specialized molecular analyses quickly and easily in an automated manner, the company says. With MODAPLEX technology, important decision-relevant biomarkers can be detected and evaluated simultaneously in a few simple steps. 

In less than four hours, the automated workflow of the MODAPLEX platform delivers fast and accurate results to pathologists and clinicians, the company says. Decision-relevant RNA and DNA biomarkers are measured simultaneously from a single sample. 

For more than ten years, the Dresden-based molecular diagnostics company has been investing in the development, production, and marketing of molecular test systems for the detection of disease-relevant genetic alterations. Now, BIOTYPE is launching the next generation of its hardware platform by simplifying the software for automated data analysis for the detection and quantification of cancer-related RNA and DNA biomarkers. 

The MODAPLEX platform is an open-system solution. BIOTYPE enables third parties, such as molecular testing system manufacturers or pharmaceutical companies, to develop and market their own assays. This approach expands the market of available tests and increases the attractiveness of MODAPLEX for users who wish to obtain their test kits from multiple sources.

BIOTYPE Enters the International Platform Business

“The launch of the next-generation MODAPLEX system also marks our entry into the international business for molecular testing platforms,” says Norman Gerstner, doctor rerum naturalium, CEO of BIOTYPE GmbH. “Last year, we repositioned the company in the rapidly growing precision medicine market. In addition to molecular tests for highly specialized diagnostics of complex diseases, we are now expanding our portfolio to include software and instruments.”

Further reading: Tecan Collaborates with Element Biosciences for Benchtop NGS

Featured image: The MODAPLEX benchtop diagnostic platform. Photo: BIOTYPE